Ark Invest Europe has appointed Paul Spells as director of northern European sales.
He was previously at Circa5000, where he was head of ETF sales UK.
Spells has also served as sales director at Orpheus Partners and a business development manager at LGBR Capital.
See also: BlackRock: Japan has ‘room to rise’ in EMEA investing
James Thomas, head of sales at Ark Invest Europe, said: “The hire marks a pivotal moment for ARK Invest, underscoring our enhanced commitment to our European investors.
“With his expertise in European market dynamics and a strong track record in selling active and sustainable strategies, Paul is well equipped to amplify our capabilities and improve our client service in this crucial region.
“We are excited to welcome Paul to our team and eagerly anticipate the fresh perspectives and vigour he will contribute to our expanding sales force as we pursue ongoing innovation and growth.”
Last month, the firm launched three strategies as Ucits vehicles, including the firm’s flagship $14bn strategy, Ark Innovation UCITS ETF (ARKK), as well as Ark Genomic Revolution UCITS ETF (ARKG).
The firm also launched a strategy made specifically for the European market, called Ark Artificial Intelligence & Robotics UCITS ETF (ARKI).
